Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ANIX

Anixa Biosciences Inc

CIK 0000715446 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$3.22
↑ 0.11 (3.54%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$109.55M
P/E Ratio
-10.92
EPS
-0.34
Dividend Yield
Not covered
52W Position
29%
Beta
1.81

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
8.28
P/S
Not covered
EV/Revenue
Not covered
ROE
-75.9%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 29%
$2.32$5.46

Latest Financials

2025-10-31 FY
Revenue
–
Net Income
-$10.93M
Total Assets
$16.08M
Free Cash Flow
–

Recent news